Mountaingate Capital-backed BioDerm completed the acquisition of Argentum Medical from Shore Capital Partners.

Mountaingate Capital-backed BioDerm, a manufacturer of proprietary hydrocolloid products, completed the acquisition of Argentum Medical, a provider of infection prevention solutions and wound care products, from Shore Capital Partners, a Chicago-based private equity firm. Financial terms were not disclosed. "Shore Capital is immensely proud of what Raul and the management team built. We are excited for Argentum to continue providing significant value to the healthcare system as an international industry leader in infection prevention management," Don Pierce, Shore Partner.